Maxcerin Capsule contains Diacerein 50mg, an anthraquinone derivative used primarily for the management of osteoarthritis. Diacerein exerts its therapeutic effect by inhibiting interleukin-1 beta, a pro-inflammatory cytokine involved in cartilage degradation and joint inflammation. This action helps reduce the progression of cartilage damage and alleviates symptoms such as joint pain and stiffness. Maxcerin is indicated for patients with symptomatic osteoarthritis, particularly of the knee and hip, where it may improve joint function and quality of life. The capsule is typically administered orally, with dosing individualized based on clinical response and tolerability. Common adverse effects include mild gastrointestinal disturbances such as diarrhea, abdominal pain, and occasional soft stools, which are generally transient and resolve with continued use. Caution is advised in patients with hepatic or renal impairment, and it should be avoided in individuals with known hypersensitivity to Diacerein or related compounds. Maxcerin is not recommended during pregnancy or lactation due to insufficient safety data. Regular monitoring of liver function tests is advisable during prolonged therapy. This medication should be used as part of a comprehensive osteoarthritis management plan, including physical therapy and lifestyle modifications, under the supervision of a healthcare professional.